FENC Earnings Date: Nov 12, 2026 (Estimated) — Fennec Pharmaceuticals Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is FENC's next earnings date?
Fennec Pharmaceuticals Inc. (FENC) is expected to report Q3 2026 earnings on Thursday, November 12, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $0.09 on revenue of $18.9M.
How did FENC do in its last earnings report?
In its most recent report on Aug 11, 2026 (Q2 2026), Fennec Pharmaceuticals Inc. posted EPS of $0.05 versus the $0.02 estimate, a beat of 150.0%. Revenue was $17.9M against a $16.2M estimate. The stock's 1-day post-earnings move was +16.8%.
How much does FENC stock move after earnings?
FENC beat EPS estimates in 4 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 13.8% (up or down) in the day after earnings.
About Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading investigational drug in clinical development is PEDMARK, a specialized formulation of sodium thiosulfate. This treatment is designed to shield young cancer patients from hearing damage (ototoxicity) that can be induced by platinum-based chemotherapy. The company, which was founded in 1996, previously operated under the name Adherex Technologies Inc. before officially rebranding as Fennec Pharmaceuticals Inc. in September 2014. Its corporate headquarters are situated in Research Triangle Park, North Carolina.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-11 | Q2 2026 | 0.02 | 0.05 | +150.00% | $17.9M | ✅ Beat | +16.82% | +8.14% | +6.49% |
| 2026-05-14 | Q1 2026 | -0.02 | 0.01 | +150.00% | $15.1M | ✅ Beat | +36.48% | +44.02% | +32.94% |
| 2026-03-24 | Q4 2025 | 0.04 | -0.17 | -525.00% | $13.8M | ❌ Miss | -19.19% | -22.55% | -10.34% |
| 2025-11-13 | Q3 2025 | -0.05 | -0.02 | +60.00% | $12.5M | ✅ Beat | +2.21% | +1.95% | +3.51% |
| 2025-08-14 | Q2 2025 | -0.04 | -0.11 | -175.00% | $9.7M | ❌ Miss | -6.37% | -11.31% | -3.84% |
| 2025-03-10 | Q4 2024 | -0.13 | -0.06 | +53.85% | $7.9M | ✅ Beat | -11.19% | -5.38% | -24.27% |
| 2024-11-07 | Q3 2024 | -0.10 | -0.21 | -110.00% | $7.0M | ❌ Miss | -11.92% | -9.49% | +24.65% |
| 2024-08-13 | Q2 2024 | -0.03 | -0.20 | -566.67% | $7.3M | ❌ Miss | -6.40% | -8.48% | -15.84% |
Showing last 8 quarters.